Self-associated indisulam in phospholipid-based nanomicelles: a potential nanomedicine for cancer
- 30 June 2009
- journal article
- Published by Elsevier BV in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 5 (2), 178-183
- https://doi.org/10.1016/j.nano.2008.09.001
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: Effects of PEG chain length and PC incorporationJournal of Pharmaceutical Sciences, 2004
- Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugsAdvanced Drug Delivery Reviews, 2004
- Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid–PEG conjugatesAdvanced Drug Delivery Reviews, 2004
- Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IXBioorganic & Medicinal Chemistry Letters, 2003
- Lipid-derivatized poly(ethylene glycol) micellar formulations of benzoporphyrin derivativesJournal of Controlled Release, 2003
- Sterically Stabilized Phospholipid Mixed Micelles: In Vitro Evaluation as a Novel Carrier for Water-Insoluble DrugsPharmaceutical Research, 2003
- Phase I and Pharmacokinetic Study of E7070, a Novel Chloroindolyl Sulfonamide Cell-Cycle Inhibitor, Administered as a One-Hour Infusion Every Three Weeks in Patients With Advanced CancerJournal of Clinical Oncology, 2002
- Polyethylene Glycol-Diacyllipid Micelles Demonstrate Increased Accumulation in Subcutaneous Tumors in MicePharmaceutical Research, 2002
- A novel formulation of VIP in sterically stabilized micelles amplifies vasodilation in vivo.Pharmaceutical Research, 1999
- Optimization of the sulforhodamine B colorimetric assayJournal of Immunological Methods, 1997